1. Home
  2. BRC vs CORT Comparison

BRC vs CORT Comparison

Compare BRC & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brady Corporation

BRC

Brady Corporation

N/A

Current Price

$73.67

Market Cap

4.1B

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$73.90

Market Cap

3.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BRC
CORT
Founded
1914
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.7B
IPO Year
2005
2001

Fundamental Metrics

Financial Performance
Metric
BRC
CORT
Price
$73.67
$73.90
Analyst Decision
Hold
Buy
Analyst Count
1
5
Target Price
$1.20
$96.50
AVG Volume (30 Days)
322.7K
1.0M
Earning Date
05-15-2026
04-30-2026
Dividend Yield
1.20%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,144,698,000.00
$761,407,000.00
Revenue This Year
$7.36
$26.08
Revenue Next Year
$3.57
$26.98
P/E Ratio
$23.35
N/A
Revenue Growth
5.86
12.79
52 Week Low
$65.76
$28.66
52 Week High
$99.29
$91.00

Technical Indicators

Market Signals
Indicator
BRC
CORT
Relative Strength Index (RSI) 33.44 80.24
Support Level $72.12 $73.79
Resistance Level $80.39 $79.89
Average True Range (ATR) 3.37 2.68
MACD -0.38 0.70
Stochastic Oscillator 2.71 91.88

Price Performance

Historical Comparison
BRC
CORT

About BRC Brady Corporation

Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: